Propranolol

Treatment for Migraine

Typical Dosage: 80-240mg daily, titrated

Effectiveness
65%
Safety Score
62%
Clinical Trials
26
Participants
25K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
62
DangerousModerateSafe
Treatment Details
Dosage Range
80-240mg daily, titrated
Time to Effect
2-4 weeks
Treatment Duration
Long-term
Evidence Quality
HIGH
Number Needed to Treat (NNT)
8(Treat 8 patients to see 1 additional successful outcome)
Confidence Score
90%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$100
Monitoring:$300
Side Effect Mgmt:$200
Total Annual:$600
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$20,000/QALY
QALYs Gained
0.07
Outcome-Based Costs
Cost per Responder
$1,500
Cost per Remission
$7,500
Propranolol Outcomes

for Migraine

Efficacy Outcomes
Overall Effectiveness
+65%
Response Rate
+40%
Remission Rate
+8%
Common Side Effects
Fatigue
+15%
Dizziness
+10%
Bradycardia
+8%
Hypotension
+5%
Nausea
+5%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
6 active trials recruiting for Propranolol in Migraine

Zonisamide Versus Propranolol in Migraine

NCT06361446RECRUITINGPHASE3
View Study
600 participants
INTERVENTIONAL
Kafr ash Shaykh, Egypt
Started: Mar 29, 2024

Valproate Versus Propranolol in Migraine

NCT06485726RECRUITINGPHASE4
View Study
600 participants
INTERVENTIONAL
Kafr ash Shaykh, Egypt
Started: Jan 23, 2023

Comparison of the Effectiveness of First-line Preventive Treatment of Migraine in Primary Care

NCT06499116NOT YET RECRUITINGPHASE4
View Study
460 participants
INTERVENTIONAL
Started: Oct 1, 2024

Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study

NCT06972056RECRUITINGPHASE4
View Study
1.33K participants
INTERVENTIONAL
Flagstaff, United States +8 more
Started: Jul 9, 2025

Comparative Study of Nutraceuticals vs. Conventional Prophylactic Therapy in the Management of Migraine

NCT07147972NOT YET RECRUITINGPHASE3
View Study
100 participants
INTERVENTIONAL
Started: Aug 20, 2025

Impact of Combined Oral Contraceptive Pills on Migraine

NCT06509503RECRUITINGPHASE4
View Study
400 participants
INTERVENTIONAL
Kafr ash Shaykh, Egypt
Started: Jul 15, 2024
Completed Clinical Trials
11 completed trials for Propranolol in Migraine

Lacosamide Versus Propranolol in Migraine

NCT05851781COMPLETEDPHASE3
View Study
600 participants
INTERVENTIONAL
Kafr ash Shaykh, Egypt
Started: Jun 1, 2022

A Study of the Efficacy and Safety of Two Doses of Topiramate Compared to Placebo and Propranolol in the Prevention of Migraine

NCT00236561COMPLETEDPHASE3
View Study
786 participants
INTERVENTIONAL
Started: Apr 1, 2001

Comparison of Propranolol and Venlafaxine in Treatment of Vestibular Migraine

NCT02350985COMPLETEDPHASE4
View Study
73 participants
INTERVENTIONAL
Istanbul, Turkey (Türkiye)
Started: Jan 1, 2014

Candesartan Versus Propranolol for Migraine Prevention

NCT00884663COMPLETEDPHASE2, PHASE3
View Study
72 participants
INTERVENTIONAL
Trondheim, Norway
Started: Apr 1, 2009

Comorbidity-Based Propranolol Use in Pediatric Migraine

NCT07103031COMPLETED
View Study
488 participants
OBSERVATIONAL
Kayseri, Turkey (Türkiye)
Started: Jan 1, 2021

Effectivity and Safety of GB20 Acupoint Pharmacopuncture With Lidocaine 2% on Migraine Patients

NCT07067853COMPLETEDNA
View Study
30 participants
INTERVENTIONAL
Jakarta Pusat, Indonesia
Started: Sep 1, 2025

Caffeine/Propranolol Intervention for Acute Migraine

NCT01080677COMPLETEDPHASE2
View Study
60 participants
INTERVENTIONAL
Stanford, United States
Started: Jan 1, 2007

NINDS CRC Chronic Migraine Treatment Trial

NCT00772031COMPLETEDPHASE3
View Study
191 participants
INTERVENTIONAL
Phoenix, United States +38 more
Started: Oct 1, 2008

Propranolol for Pediatric Migraine: A Prospective Clinical Study

NCT07180043COMPLETEDNA
View Study
178 participants
INTERVENTIONAL
Kayseri, Turkey (Türkiye)
Started: Jan 1, 2021

An Efficacy and Tolerability Study of Topiramate in Participants With Migraine

NCT01060111COMPLETEDPHASE4
View Study
250 participants
INTERVENTIONAL
Busan, South Korea +5 more
Started: Jul 1, 2006

Drug and Non-Drug Treatment Of Severe Migraine

NCT00910689COMPLETEDPHASE4
View Study
232 participants
INTERVENTIONAL
Athens, United States +1 more
Started: Jul 1, 2001
Showing 20 of 26 total trials